Caira, Morena
 Distribuzione geografica
Continente #
EU - Europa 3.615
NA - Nord America 3.285
AS - Asia 2.207
SA - Sud America 346
AF - Africa 49
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.511
Nazione #
US - Stati Uniti d'America 3.218
DE - Germania 1.926
SG - Singapore 1.049
CN - Cina 634
SE - Svezia 362
UA - Ucraina 330
BR - Brasile 270
FR - Francia 215
IT - Italia 160
PL - Polonia 154
GB - Regno Unito 146
VN - Vietnam 135
IE - Irlanda 111
IN - India 76
FI - Finlandia 69
ID - Indonesia 69
RU - Federazione Russa 66
TR - Turchia 49
JP - Giappone 35
MX - Messico 35
AR - Argentina 33
IQ - Iraq 32
BD - Bangladesh 24
HK - Hong Kong 24
CA - Canada 22
ZA - Sudafrica 16
NL - Olanda 14
SA - Arabia Saudita 13
BE - Belgio 11
ES - Italia 11
VE - Venezuela 11
CO - Colombia 9
PK - Pakistan 9
UZ - Uzbekistan 9
CL - Cile 8
EC - Ecuador 8
KE - Kenya 8
IR - Iran 6
KZ - Kazakistan 6
AU - Australia 5
CI - Costa d'Avorio 5
IL - Israele 5
AL - Albania 4
AT - Austria 4
EG - Egitto 4
HU - Ungheria 4
JO - Giordania 4
LT - Lituania 4
MA - Marocco 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
BO - Bolivia 3
CH - Svizzera 3
KR - Corea 3
MD - Moldavia 3
MY - Malesia 3
NG - Nigeria 3
PH - Filippine 3
RO - Romania 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EU - Europa 2
GR - Grecia 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BM - Bermuda 1
BY - Bielorussia 1
CG - Congo 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 9.511
Città #
Singapore 536
Chandler 474
Ashburn 434
San Jose 289
Jacksonville 196
Warsaw 147
San Mateo 145
Nürnberg 120
Dublin 110
Ann Arbor 102
Beijing 95
Dearborn 94
Nanjing 91
Woodbridge 77
New York 73
Wilmington 73
Jakarta 65
Bremen 63
Lauterbourg 61
Lawrence 56
Boston 52
Hefei 50
Houston 50
Los Angeles 47
Munich 47
Hanoi 45
Moscow 42
Milan 41
Nanchang 40
Zhengzhou 39
Ho Chi Minh City 38
Izmir 34
Seattle 33
Fairfield 31
Frankfurt am Main 31
Buffalo 30
Marseille 30
Tokyo 28
São Paulo 27
Lancaster 25
Kunming 24
Hong Kong 23
University Park 22
Shanghai 21
Hebei 20
Tianjin 20
Shenyang 19
Redwood City 18
Mountain View 17
Boardman 16
Jiaxing 15
Kent 15
Changsha 14
Cuauhtémoc 14
Philadelphia 14
Santa Clara 14
Rome 13
Baghdad 12
Chicago 12
Leawood 12
Memphis 12
Brussels 11
Dallas 11
Cambridge 10
Guangzhou 10
Hangzhou 10
Orem 10
Pune 10
Fremont 9
Mexico City 9
Porto Alegre 9
Auburn Hills 8
Nuremberg 8
St Louis 8
Atlanta 7
Costa Mesa 7
Düsseldorf 7
Kraków 7
Nairobi 7
Norwalk 7
Princeton 7
Rio de Janeiro 7
Toronto 7
Amsterdam 6
Cattolica 6
Haiphong 6
London 6
Phoenix 6
Riyadh 6
Tashkent 6
Abidjan 5
Augusta 5
Belo Horizonte 5
Brooklyn 5
Campinas 5
Da Nang 5
Indiana 5
Jinan 5
Montreal 5
Paris 5
Totale 4.686
Nome #
Incidence of acute myeloid leukemia after breast cancer 384
Factors associated with mortality in bacteremic patients with hematologic malignancies. 374
Factors associated with mortality in bacteremic patients with haematologic malignancies 356
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 354
A prospective survey of febrile events in hematological malignancies 307
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 228
Factors associated with mortality in bacteremic patients with hematologic malignancies. 218
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 211
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 211
Increased production of gliotoxin is related to the formation of biofilm byAspergillus fumigatus: an immunological approach 201
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 196
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 194
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 183
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 169
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 164
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 161
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 159
A prospective survey of febrile events in hematological malignancies 156
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 152
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 152
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 152
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies 151
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 149
A prospective survey of febrile events in hematological malignancies 149
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 149
Advanced mast cell disease: an Italian Hematological Multicenter experience. 148
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 148
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 146
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 144
A patient with acute myeloid leukemia and a solid mass in the colon. 142
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report 137
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 134
Uncommon yeast infections in hematological patients: from diagnosis to treatment 133
Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. 132
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 132
First case of breakthrough pneumonia due to Aspergillus nomius in a patient with acute myeloid leukemia 132
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients 130
Caspofungin for the treatment of candidaemia in patients with haematological malignancies 129
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? 124
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 123
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients 121
The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients. 120
Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment 116
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey 116
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 114
Current therapeutic approaches to fungal infections in immunocompromised hematological patients 113
The role of primary antifungal prophylaxis in patients with haematological malignancies 112
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 111
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 111
Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B Registry 105
The role of neutrophils in the development and outcome of zygomycosis in haematological patients 104
Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation 101
Invasive fungal infections in patients with acute myeloid leukcemia and in those submitted to allogenic hemopoietic stem cell transplant: Who is at highest risk?. 98
Etiology of Febrile Episodes in Patients With Acute Myeloid Leukemia: Results From the Hema e-Chart Registry 97
ZYGOMYCOSIS: Current approaches to management of patients with haematological malignancies. 96
. Pulmonary aspergillosis: lights and shadows 95
Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient 83
Invasive aspergillosis in acute leukemias: old and new risk factors and epidemiological trends 79
Hema e-Chart Registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections 76
Italian Hema e-Chart Group.Continuous surveillance of invasive fungal infection: a realistic goal for the near future. 75
The management of febrile neutropenia in the posaconazole era: a new challenge? 73
Uncommon yeast infections in hematological patients: from diagnosis to treatment 72
Risks for infection in patients with myelodysplasia and acute leukemia 66
Totale 9.568
Categoria #
all - tutte 34.013
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.013


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/2022561 72 60 7 24 16 11 13 86 25 42 71 134
2022/20231.207 123 174 109 224 92 163 45 104 138 5 25 5
2023/2024439 32 155 6 8 14 70 33 8 4 9 62 38
2024/2025934 40 36 67 15 104 32 15 43 190 69 169 154
2025/20262.489 386 61 132 205 458 143 462 159 179 188 62 54
Totale 9.568